Search | All Crowdz

Databridge Market Research added blog Other
2025-07-24 09:35:27 -

Europe Long Read Sequencing Market Size, Share, Trends, Growth Opportunities, Key Drivers and Competitive Outlook
"Executive Summary Europe Long Read Sequencing Market : Data Bridge Market Research analyses that the long read sequencing market, which was USD 515.64 million in 2022, would be up to USD 2514.06 million by 2030 and is expected to undergo a CAGR of 21.9% during the forecast period 2023-2030. The Europe Long Read Sequencing Market research report concentrates on the foremost...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
John774 Anderson added blog Health
2026-04-27 13:18:26 -

Long Read Sequencing Market Growth in USA: Key Players, Trends, and Opportunities by 2028
The Long read sequencing, often referred to as third-generation sequencing, is revolutionizing genomic research by offering longer read lengths and better structural variation detection compared to conventional methods. The market is witnessing significant traction due to the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and genetic conditions. As researchers...

0 Comments 0 Shares 129 Views 0 Reviews

Please log in to like, share and comment!
Databridge Market Research added blog Other
2025-07-27 04:25:56 -

Middle East and Africa Long Read Sequencing Market Size, Share, Trends, Growth Opportunities and Competitive Outlook
"Executive Summary Middle East and Africa Long Read Sequencing Market : Data Bridge Market Research analyses that the long read sequencing market which is USD 23.11 million in 2022, is expected to reach USD 96.10 million by 2030, at a CAGR of 19.5% during the forecast period 2023 to 2030. Middle East and Africa Long Read Sequencing Market report endows with superior market...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
Onkar Dhakane added blog Networking
2026-04-01 14:02:00 -

How Long Read Sequencing Is Transforming Precision Medicine
The genomic frontier has moved. The era of "good enough" short-read data is hitting a structural ceiling, and the surge in Long-Read Sequencing (LRS) is no longer a niche academic interest—it is a competitive necessity. For organizations in clinical diagnostics, agricultural biotech, and pharmaceutical R&D, the question is no longer about the cost per base, but the cost of...

0 Comments 0 Shares 342 Views 0 Reviews

Please log in to like, share and comment!